Related Experiment Video
Updated: Apr 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Medication-taking behavior in hypertensive patients with a single-tablet, fixed-dose combination in Japan
Ikuo Saito1, Toshio Kushiro2, Yasuyuki Matsushita3
1a Keio University Health Center , Kanagawa , Japan .
Abstract:
Non-persistence rate (defined as not remaining on treatment) in patients taking a renin angiotensin system inhibitor plus calcium channel blocker was studied in three integrated 12-weeks surveys by matching separate drug combination therapy (CT) and fixed-dose combination (FDC). We also investigated medication adherence measured by proportion of days covered by using a claims database. The non-persistence rate was significantly lower in FDC than CT (p = 0.0074). In the database study, the medication adherence was higher in FDC than CT for 3, 6, and 12 months (all p < 0.001). In conclusion, use of single-tablet FDC antihypertensive therapy was associated with better medication-taking behavior.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Antihypertensive Drugs: Direct Renin Inhibitors
Drug Dosing: Geriatric Patients
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Types of β-Blockers

